Supports capital-efficient expansion of the SLS009 clinical program into frontline AML, enabling broader U.S. and European patient enrollment ...

Blood Cancer United®, formerly The Leukemia & Lymphoma Society, announced today that the first patient has received treatment ...

AVEO Oncology, an LG Chem company, (AVEO) announced today that the first patient has been successfully dosed in a Phase 1b/2 clinical trial evaluating ficlatuzumab in combination with azacitidine and ...

Under the revised EU AML/CFT package, institutions are expected to adopt more sophisticated, proactive approaches to ...

In this secondary analysis of the ECOG-ACRIN E2906 study, researchers assessed vulnerabilities of AML patients aged 60 years or older and their affect on survival outcomes.

The single largest penalty of 2025, at $985 million (EUR835 million), was issued to a Swiss bank by French authorities in relation to AML failings. As a result, France became the second-largest ...

Researchers sought to determine whether combining enasidenib with venetoclax would be effective in patients with IDH2-mutated ...

The global anti-money laundering (AML) system market size was US$ 2.5 billion in 2021. The global anti-money laundering (AML) system market is forecast to grow to US$ 7.5 billion by 2030 by growing at ...

It said that higher costs and added administrative burden could lead some companies to discontinue membership of professional ...

IBS Intelligence (IBSi) is the world’s only pure-play Financial Technology focused research, advisory, and fintech news ...